Skip to content
CFPS Research Archives

KPV

Early human Healing & Recovery In 3 protocols 2 sources

KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.

01Dosing reference

Amount
200-500 mcg/day
Frequency
Once or twice daily
Cycle
4-8 weeks on, followed by a break
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Cellular Penetration and Receptor Interaction

KPV enters cells and interacts with inflammatory signaling molecules, and may also bind to melanocortin-1 receptors (MC1R).

02

NF-kB Inhibition

It inhibits the activation and nuclear translocation of NF-kB, a major transcription factor responsible for inflammatory responses.

03

Cytokine Reduction

This inhibition leads to a significant decrease in the production of pro-inflammatory cytokines, reducing systemic and localized inflammation.

03Human evidence

Topical application of KPV has shown efficacy in reducing skin inflammation and erythema.

Early clinical observations in patients with psoriasis and other inflammatory skin conditions.

Oral and systemic administration may help manage symptoms of inflammatory bowel disease (IBD).

Preliminary human data supporting extensive preclinical models of colitis, though large-scale trials are still needed.

04Preclinical evidence

KPV significantly reduced colonic inflammation and promoted mucosal healing.

Mouse models of DSS-induced colitis, demonstrating its potential for treating IBD.

Exhibited antimicrobial properties against pathogens like Staphylococcus aureus and Candida albicans.

In vitro studies showing KPV's ability to inhibit microbial growth alongside its anti-inflammatory effects.

05What is known vs. unknown

Reasonably established
  • KPV is a tripeptide consisting of the amino acids Lysine, Proline, and Valine.
  • It is derived from the C-terminal region of alpha-MSH but does not cause skin pigmentation.
  • Its primary mechanism of action is the potent inhibition of the NF-kB inflammatory pathway.
  • Research indicates it has both anti-inflammatory and antimicrobial properties.
Unknowns & limits
  • Long-term safety and efficacy in large-scale, randomized human clinical trials remain unestablished.
  • The optimal delivery method (oral, topical, or subcutaneous) for specific systemic versus localized conditions is still being researched.

06Safety & regulatory context

Regulatory statusIn research settings, KPV is generally considered to have a favorable safety profile with minimal reported side effects. Because it lacks the melanotropic sequence of full-length alpha-MSH, it does not induce skin darkening. It is not FDA-approved for the treatment, diagnosis, or prevention of any disease and is available strictly for research and educational purposes.

07Compared with BPC-157

KPV vs. BPC-157
Key difference
KPV primarily acts by directly inhibiting inflammatory pathways (NF-kB) and has antimicrobial properties, whereas BPC-157 focuses on promoting angiogenesis and tissue repair via nitric oxide pathways.
When researchers discuss each
Researchers often discuss KPV for autoimmune, skin, or gut inflammatory conditions (like IBD or psoriasis), while BPC-157 is typically favored for musculoskeletal injuries and rapid tissue healing.

08Appears in protocols

🩹 Injury Recovery Protocol

200 mcg/dayDaily

🛡️ Immune Defense Protocol

200 mcg/dayDaily

🌿 Gut Health & Healing Protocol

200-500 mcg/dayDaily

09Glossary

Alpha-MSH
Alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in regulating pigmentation and inflammation.
NF-kB
A protein complex that controls the transcription of DNA and plays a critical role in regulating the immune response to infection and inflammation.
Tripeptide
A small protein fragment consisting of exactly three amino acids linked together.

10Knowledge check

Q1What is the primary mechanism by which KPV exerts its anti-inflammatory effects?
Q2Unlike its parent peptide alpha-MSH, what side effect does KPV avoid?
Q3Which statement best reflects the current quality of human clinical evidence supporting KPV for inflammatory conditions, based on the dossier?
Q4Which option most accurately captures the dossier's stated comparison between KPV and BPC-157?
Q5Which statement about KPV's regulatory and safety status is supported by the dossier?

11Sources

More in Healing & Recovery

See all

BPC-157

Healing & Recovery
Early human

BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.

250-500 mcg

TB-500 (Thymosin Beta-4)

Healing & Recovery
Early human

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.

2.0 - 2.5 mg per injection

Wolverine Blend (BPC-157 + TB-500)

Healing & Recovery
Preclinical only

The 'Wolverine Blend' is a popular research combination of two well-known healing peptides: BPC-157 and TB-500 (Thymosin Beta-4). Research suggests that BPC-157 promotes angiogenesis and gastrointestinal healing, while TB-500 upregulates actin, facilitating cell migration and tissue repair. Together, they are studied for their synergistic potential in accelerating recovery from muscle, tendon, and ligament injuries.

BPC-157: 250-500 mcg/day; TB-500: 2-5 mg/week
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.